Biogen | BIIB - EPS Earnings Per Share


Biogen reported $2.62 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 2.62 3.83 4.81 Oct/28
FY2026Q2 Jun/2026 3.60 3.21 5.47 Jul/29
FY2026Q1 Mar/2026 3.57 3.06 3.02 Apr/29
FY2025Q4 Dec/2025 1.99 1.74 3.44 Feb/06
FY2025Q3 Sep/2025 4.81 3.84 4.08 Oct/30




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Acadia Pharmaceuticals USD 0.31 0.13 Sep/2026
ALKERMES USD 0.09 0.09 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
Bayer EUR 0.31 0.64 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Moderna USD 0.38 2.35 Sep/2026
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 3.55 1.46 Sep/2026
Sanofi EUR 0.14 2.02 Jun/2026
Sarepta Therapeutics USD 0.13 0.51 Sep/2026
Teva Pharmaceutical Industries USD 0.79 0.73 Sep/2026
Ultragenyx Pharmaceutical USD -1.16 0.26 Sep/2026
United Therapeutics USD 5.71 1.56 Sep/2026
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026